Literature DB >> 30205334

Computer-aided classification of prostate cancer grade groups from MRI images using texture features and stacked sparse autoencoder.

Bejoy Abraham1, Madhu S Nair2.   

Abstract

A novel method to determine the Grade Group (GG) in prostate cancer (PCa) using multi-parametric magnetic resonance imaging (mpMRI) biomarkers is investigated in this paper. In this method, high-level features are extracted from hand-crafted texture features using a deep network of stacked sparse autoencoders (SSAE) and classified them using a softmax classifier (SMC). Transaxial T2 Weighted (T2W), Apparent Diffusion Coefficient (ADC) and high B-Value Diffusion-Weighted (BVAL) images obtained from PROSTATEx-2 2017 challenge dataset are used in this technique. The method was evaluated on the challenge dataset composed of a training set of 112 lesions and a test set of 70 lesions. It achieved a quadratic-weighted Kappa score of 0.2772 on evaluation using test dataset of the challenge. It also reached a Positive Predictive Value (PPV) of 80% in predicting PCa with GG > 1. The method achieved first place in the challenge, winning over 43 methods submitted by 21 groups. A 3-fold cross-validation using training data of the challenge was further performed and the method achieved a quadratic-weighted kappa score of 0.2326 and Positive Predictive Value (PPV) of 80.26% in predicting PCa with GG > 1. Even though the training dataset is a highly imbalanced one, the method was able to achieve a fair kappa score. Being one of the pioneer methods which attempted to classify prostate cancer into 5 grade groups from MRI images, it could serve as a base method for further investigations and improvements.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep learning; Gleason grade; Multiparametric MRI; Prostate cancer; Stacked sparse autoencoder; Texture features

Mesh:

Year:  2018        PMID: 30205334     DOI: 10.1016/j.compmedimag.2018.08.006

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  7 in total

1.  Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.

Authors:  Amogh Hiremath; Rakesh Shiradkar; Harri Merisaari; Prateek Prasanna; Otto Ettala; Pekka Taimen; Hannu J Aronen; Peter J Boström; Ivan Jambor; Anant Madabhushi
Journal:  Eur Radiol       Date:  2020-07-23       Impact factor: 5.315

Review 2.  Challenges in ensuring the generalizability of image quantitation methods for MRI.

Authors:  Kathryn E Keenan; Jana G Delfino; Kalina V Jordanova; Megan E Poorman; Prathyush Chirra; Akshay S Chaudhari; Bettina Baessler; Jessica Winfield; Satish E Viswanath; Nandita M deSouza
Journal:  Med Phys       Date:  2021-09-29       Impact factor: 4.506

3.  Adversarial training for prostate cancer classification using magnetic resonance imaging.

Authors:  Lei Hu; Da-Wei Zhou; Xiang-Yu Guo; Wen-Hao Xu; Li-Ming Wei; Jun-Gong Zhao
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 4.  Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities.

Authors:  Huanye Li; Chau Hung Lee; David Chia; Zhiping Lin; Weimin Huang; Cher Heng Tan
Journal:  Diagnostics (Basel)       Date:  2022-01-24

5.  Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).

Authors:  Olivier Rouvière; Rémi Souchon; Carole Lartizien; Adeline Mansuy; Laurent Magaud; Matthieu Colom; Marine Dubreuil-Chambardel; Sabine Debeer; Tristan Jaouen; Audrey Duran; Pascal Rippert; Benjamin Riche; Caterina Monini; Virginie Vlaeminck-Guillem; Julie Haesebaert; Muriel Rabilloud; Sébastien Crouzet
Journal:  BMJ Open       Date:  2022-02-09       Impact factor: 2.692

6.  Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy.

Authors:  Lizhi Shao; Ye Yan; Zhenyu Liu; Xiongjun Ye; Haizhui Xia; Xuehua Zhu; Yuting Zhang; Zhiying Zhang; Huiying Chen; Wei He; Cheng Liu; Min Lu; Yi Huang; Lulin Ma; Kai Sun; Xuezhi Zhou; Guanyu Yang; Jian Lu; Jie Tian
Journal:  Theranostics       Date:  2020-09-02       Impact factor: 11.556

Review 7.  Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies.

Authors:  Simon K B Spohn; Alisa S Bettermann; Fabian Bamberg; Matthias Benndorf; Michael Mix; Nils H Nicolay; Tobias Fechter; Tobias Hölscher; Radu Grosu; Arturo Chiti; Anca L Grosu; Constantinos Zamboglou
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.